Pfizer Limited (BOM:500680)
India · Delayed Price · Currency is INR | Market Cap | 220.68B -8.3% |
| Revenue (ttm) | 25.70B +10.7% |
| Net Income | 7.35B -9.1% |
| EPS | 160.70 -9.1% |
| Shares Out | n/a |
| PE Ratio | 30.02 |
| Forward PE | 25.62 |
| Dividend | 75.00 (1.58%) |
| Ex-Dividend Date | Jul 17, 2026 |
| Volume | 761 |
| Open | 4,837.55 |
| Previous Close | 4,799.05 |
| Day's Range | 4,782.95 - 4,847.90 |
| 52-Week Range | 4,361.00 - 5,878.55 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 6,331.25 (+31.28%) |
| Earnings Date | Jul 28, 2026 |
About Pfizer
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterology, pain management, and nutrition, addressing. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products t... [Read more]
Financial Performance
In fiscal year 2026, Pfizer's revenue was 25.20 billion, an increase of 10.45% compared to the previous year's 22.81 billion. Earnings were 7.22 billion, a decrease of -5.88%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for 500680 stock is "Strong Buy." The 12-month stock price target is ₹6,331, which is an increase of 31.28% from the latest price.
News
Pfizer Quarterly report: Q1 2027
Pfizer has published its Q1 2027 quarterly earnings report on July 28, 2026.
Pfizer announces Rs 75 per share final dividend with record date set for July 17, 2026
Pfizer Limited has announced a final dividend of ₹75 per equity share for the financial year ending March 31, 2026. The company has set the record date for the final…
Pfizer Quarterly report: Q4 2026
Pfizer has published its Q4 2026 quarterly earnings report on May 12, 2026.
Pfizer Annual report: Q4 2026
Pfizer has published its Q4 2026 annual report on May 12, 2026.
Pfizer Quarterly report: Q3 2026
Pfizer has published its Q3 2026 quarterly earnings report on February 9, 2026.
Pfizer appoints Nilesh Pendse as vaccines category lead; Manikantan Seshadrinathan exits senior management
Pfizer Limited informed stock exchanges on January 20, 2026, about multiple changes in its senior management personnel, in compliance with...
Pfizer signs exclusive 5-year supply and marketing pact with Cipla for four key brands
Pfizer Limited on Thursday announced that it has entered into an exclusive supply and marketing agreement with Cipla for four...
Pfizer shares jump over 5% as Q2 profit rises 19% YoY on strong operational performance
Shares of Pfizer Ltd surged 5.83% to Rs 5,308 on Thursday, November 13, after the company reported a solid set...
Pfizer Quarterly report: Q2 2026
Pfizer has published its Q2 2026 quarterly earnings report on November 12, 2025.
Pfizer shares jump over 5% as Q1 net profit surges 27.2% YoY
Pfizer Ltd’s shares surged 5.4% to ₹5,385 in early trade on Thursday after the pharmaceutical company reported robust first-quarter results for FY26. The company’s net profit grew 27.2% year-on-year (...
Pfizer Quarterly report: Q1 2026
Pfizer has published its Q1 2026 quarterly earnings report on August 13, 2025.
Pfizer shares jump over 2% after launch of next-gen 20-valent pneumococcal vaccine in India
Shares of Pfizer Limited rose 2.07% to Rs 5,165.50 on Tuesday, August 12, following the company’s announcement of the launch of its next-generation 20-valent Pneumococcal Polysaccharide Conjugate Vacc...